Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Pro members get actionable news alerts up to 30 minutes before other traders — Get our lowest prices
Pro members get actionable news alerts up to 30 minutes before other traders — Get our lowest prices
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Omega Therapeutics Inc has a consensus price target of $9.43 based on the ratings of 7 analysts. The high is $12 issued by HC Wainwright & Co. on August 15, 2024. The low is $4 issued by Goldman Sachs on May 24, 2022. The 3 most-recent analyst ratings were released by HC Wainwright & Co., Wedbush, and Chardan Capital on August 15, 2024, August 7, 2024, and August 7, 2024, respectively. With an average price target of $10 between HC Wainwright & Co., Wedbush, and Chardan Capital, there's an implied 614.34% upside for Omega Therapeutics Inc from these most-recent analyst ratings.
1calculated from analyst ratings
The latest price target for Omega Therapeutics (NASDAQ:OMGA) was reported by HC Wainwright & Co. on August 15, 2024. The analyst firm set a price target for $12.00 expecting OMGA to rise to within 12 months (a possible 757.20% upside). 12 analyst firms have reported ratings in the last year.
The latest analyst rating for Omega Therapeutics (NASDAQ:OMGA) was provided by HC Wainwright & Co., and Omega Therapeutics reiterated their buy rating.
There is no last upgrade for Omega Therapeutics
There is no last downgrade for Omega Therapeutics.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Omega Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Omega Therapeutics was filed on August 15, 2024 so you should expect the next rating to be made available sometime around August 15, 2025.
While ratings are subjective and will change, the latest Omega Therapeutics (OMGA) rating was a reiterated with a price target of $12.00 to $12.00. The current price Omega Therapeutics (OMGA) is trading at is $1.40, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.